Warren Street Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.5M Sell
20,698
-17
-0.1% -$5.82K 1.67% 15
2026
Q1
$7.29M Buy
20,715
+16,488
+390% +$5.88M 1.85% 13
2025
Q4
$1.38M Sell
4,227
-1,451
-26% -$460K 0.4% 30
2025
Q3
$1.6M Buy
5,678
+84
+2% +$24.4K 0.48% 33
2025
Q2
$1.56M Buy
5,594
+4,672
+507% +$1.32M 0.51% 31
2025
Q1
$287K Buy
+922
New +$272K 0.11% 80
2024
Q4
Sell
-767
Closed -$247K 106
2024
Q3
$247K Buy
767
+51
+7% +$16.7K 0.1% 84
2024
Q2
$224K Buy
+716
New +$210K 0.11% 88

Other funds holding AMGN

Warren Street Wealth Advisors's AMGN Position: Q2 2026 in Review

Warren Street Wealth Advisors reduced its Amgen (AMGN) stake by 0.08% in Q2 2026, selling an estimated $5.82K and leaving 20,698 shares worth $7.5M. The position accounts for 1.67% of the portfolio, ranked #15.

Warren Street Wealth Advisors first reported a position in AMGN in Q2 2024 and has held it in 8 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Warren Street Wealth Advisors held 20,698 shares of Amgen worth $7.5M as of Q2 2026.
  • Warren Street Wealth Advisors sold 17 Amgen shares in Q2 2026, an estimated $5.82K.
  • Amgen made up 1.67% of Warren Street Wealth Advisors's portfolio in Q2 2026, its #15 holding.
  • Warren Street Wealth Advisors first reported a position in Amgen in Q2 2024 and has held it in 8 quarters since.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Warren Street Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.